Myriad Genetic Laboratories, Inc. is a biopharmaceutical company that focuses on developing new therapeutic and predictive medicine products. Myriad Genetic Laboratories uses innovative technology to perform genetic testing of the highest quality available. Already a world leader in offering a range of hereditary cancer predictive medicine products, we are currently developing pharmacogenetic testing products.
The era of a more effective use of medicines is upon us, one in which patients are evaluated in advance in order to receive more targeted therapy. We see an explosion in the growth of pharmacogenetic testing and intend to participate in that growth through the development and introduction of innovative products.
TheraGuide 5-FU™ is the first of these products. It is a simple blood test that allows your physician to customize treatment and minimize risk for an adverse reaction to 5-FU–related chemotherapy.
We encourage you to explore our Web site to learn about the first of our pharmacogenetic testing products, TheraGuide 5-FU™.